BioCentury | Jan 27, 2017
Clinical News

Tafoxiparin: Ph IIb started

...began a double-blind, placebo-controlled, European Phase IIb trial to evaluate 3 dose levels of IV tafoxiparin...
...36 hours in about 360 term-pregnant, nulliparous women. Dilafor AB , Solna, Sweden Product: Tafoxiparin (DF01...
...vaginal partus and proportion of women with cesarean sections Status: Phase IIb started Milestone: NA Chris Lieu DF01 Tafoxiparin Dilafor...
BioCentury | Sep 20, 2010
Company News

Dilafor, Lee's Pharmaceutical deal

...exclusive development and commercialization rights in China, including Hong Kong and Macau, and Taiwan to tafoxiparin...
...of the product, but did not disclose a timeline for when the trials will start. Tafoxiparin...
BioCentury | Sep 14, 2009
Clinical News

Tafoxiparin: Phase II data

...Data from a double-blind, Swedish Phase II trial in 263 women showed that tafoxiparin missed the...
...missed the primary endpoint of significantly reducing time of labor vs. placebo (p-value not disclosed). Tafoxiparin...
...labor vs. placebo. Tafoxiparin was well tolerated. Dilafor AB , Stockholm, Sweden Product: Tafoxiparin ( DF01...
Items per page:
1 - 3 of 3